http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109942547-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109942547-B |
| titleOfInvention | Novel quinoline-substituted triazole compound with biological activity and synthesis method and application thereof |
| abstract | The invention discloses a novel quinoline substituted triazole compound with bioactivity, and a synthesis method and application thereof, and belongs to the technical field of quinoline and triazole derivatives with bioactivity. The technical scheme provided by the invention has the key points that: a novel quinoline substituted triazole compound with biological activity has a structural formula as follows: the novel quinoline substituted triazole compound with biological activity is used as an enzyme activity inhibitor of SHP1 target and an enzyme activity inhibitor of SHP1 target, and is used for preparing anticancer drugs. In view of the good activity of the quinoline group and the triazole compound, the quinoline group is introduced into triazole according to the active splicing principle to obtain the novel quinoline substituted triazole compound with bioactivity, and the quinoline substituted triazole compound has a good application prospect in the field of preparation of anti-cancer drugs. |
| priorityDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.